STERIS plc (NYSE:STE – Get Rating)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as $191.58 and last traded at $191.96, with a volume of 3027 shares. The stock had previously closed at $193.72.
Analysts Set New Price Targets
STE has been the subject of several recent research reports. Needham & Company LLC lowered their price target on shares of STERIS from $248.00 to $237.00 and set a “buy” rating for the company in a research report on Thursday, August 4th. StockNews.com upgraded shares of STERIS from a “hold” rating to a “buy” rating in a research report on Thursday, August 11th. JMP Securities decreased their target price on shares of STERIS from $270.00 to $250.00 in a research report on Thursday, August 4th. Piper Sandler started coverage on shares of STERIS in a research report on Thursday, July 14th. They issued an “overweight” rating and a $240.00 target price for the company. Finally, TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a report on Tuesday, August 2nd. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $252.00.
STERIS Stock Down 3.7 %
The company has a quick ratio of 1.35, a current ratio of 2.03 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $18.31 billion, a PE ratio of 49.09 and a beta of 0.75. The business’s 50 day simple moving average is $208.32 and its 200 day simple moving average is $219.52.
STERIS Increases Dividend
Institutional Trading of STERIS
Hedge funds have recently bought and sold shares of the company. Tcwp LLC purchased a new stake in STERIS during the first quarter valued at about $25,000. 1832 Asset Management L.P. purchased a new stake in shares of STERIS in the first quarter worth approximately $25,000. Riverview Trust Co purchased a new stake in shares of STERIS in the first quarter worth approximately $29,000. Urban Wealth Management LLC purchased a new stake in shares of STERIS in the second quarter worth approximately $33,000. Finally, J.W. Cole Advisors Inc. purchased a new stake in shares of STERIS in the first quarter worth approximately $37,000. 92.04% of the stock is owned by hedge funds and other institutional investors.
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
- Get a free copy of the StockNews.com research report on STERIS (STE)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.